LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Medlab Asia and Asia Health to Host First-Ever Live, In-Person Event in Thailand

By LabMedica International staff writers
Posted on 27 Jul 2022
Print article
Image: Medlab Asia and Asia Health will take place live and in-person in Thailand (Photo courtesy of Informa Markets)
Image: Medlab Asia and Asia Health will take place live and in-person in Thailand (Photo courtesy of Informa Markets)

Informa Markets (London, UK), in partnership with Impact Muang Thong Thani (Nonthaburi, Thailand), have confirmed that Medlab Asia and Asia Health will take place in Thailand for the first time when the co-located events return live and in-person at the Impact Exhibition Center, Bangkok, from 19-21 October 2022. The exhibitions, the leading events in the ASEAN region for the healthcare and laboratory industry, will showcase the latest techniques and innovations while also welcoming visitors and suppliers from around the world to meet, discuss and do business in the burgeoning healthcare hub of Thailand.

According to government data, sales of clinical laboratory services in Thailand are expected to increase to USD 8.3 billion in 2026, from USD 4.5 billion in 2016. The healthcare sector in the country has also seen a surge in the number of international patients it welcomes, with current figures standing at two million. However, this figure is expected to increase. The co-located events are expected to welcome more than 4,200 attendees during the 10th edition of both events, with more than 300 exhibitors from over 20 countries showcasing the latest innovation in product development and new technologies and insights supporting the healthcare and laboratory industries. Both events are once again expected to be supported by a host of government entities, industry leaders and influencers in their respective sectors.

Forming a vital attribute of both events are the CME, CMTE, CNEU & CPD accredited conferences, each designed to provide peer-to-peer networking while fostering knowledge through insights and expert analysis. Medlab Asia will host six conference tracks, including Laboratory Management, Clinical Chemistry, Clinical Microbiology, Molecular Diagnostics & Therapeutics, Hematology and COVID-19 Updates. The congress focus for Asia Health will look, in detail, at Hospital Procurement, Sterilization, Decontamination & Patient Safety, Doing Healthcare Business in Thailand and Total Radiology. This will be supported by workshops featuring latest technologies in the ASEAN healthcare sector.

A host of exhibitors have already committed to attending the three-day showcase. They include, amongst others, Randox laboratories Ltd, Singapore-based GenScript Biotech, College of American Pathologists, Trivitron Healthcare, Sysmex Asia Pacific, BGI Genomics Co, and Sansure Biotech. As part of Informa's commitment to providing the highest hygiene and safety levels, the event will again take place under the protocols introduced via the company’s Informa AllSecure health and safety mandate. The enhanced measures include 35 guidelines covering all aspects of cleaning and hygiene, social distancing measures, screening, and a track and trace in conjunction with local authorities.

“We are delighted to be relaunching Medlab Asia and Asia Health as a co-located event in Thailand. Both events have been integral to developing the healthcare and laboratory sectors in the ASEAN region over the last decade,” said Tom Coleman, Exhibition Director for Informa Markets. “This is something we are committed to continuing, to ensure the latest technology and insights are given a platform in the region and that both events continue to play a pivotal role in connecting those within the healthcare and laboratory industries.”

“The healthcare industry has faced unprecedented challenges in recent years; however, the industry should be applauded for its efforts in supporting the recovery of businesses globally while also ensuring economic recovery,” added Loy Joon How, General Manager, Impact Muang Thong Thani.

Related Links:
Informa Markets 
Impact Muang Thong Thani
Medlab Asia 
Asia Health 

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
New
Gold Member
Liquid Ready-To-Use Lp(a) Reagent
Lipoprotein (a) Reagent

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: The AI predictive model identifies the most potent cancer killing immune cells for use in immunotherapies (Photo courtesy of Shutterstock)

AI Predicts Tumor-Killing Cells with High Accuracy

Cellular immunotherapy involves extracting immune cells from a patient's tumor, potentially enhancing their cancer-fighting capabilities through engineering, and then expanding and reintroducing them into the body.... Read more

Microbiology

view channel
Image: The T-SPOT.TB test is now paired with the Auto-Pure 2400 liquid handling platform for accurate TB testing (Photo courtesy of Shutterstock)

Integrated Solution Ushers New Era of Automated Tuberculosis Testing

Tuberculosis (TB) is responsible for 1.3 million deaths every year, positioning it as one of the top killers globally due to a single infectious agent. In 2022, around 10.6 million people were diagnosed... Read more